Tag: home-based care
HeartBeam receives US FDA Breakthrough Device designation for heart attack assessment
HeartBeam has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for the HeartBeam system as a tool for...
Individualised home-based education dramatically decreases atrial fibrillation-related hospitalisations and other cardiovascular...
Personalised education delivered in a home setting significantly reduces hospitalisations in patients with atrial fibrillation (AF). This was among the findings of the HELP-AF...

